EUS in the Literature

Manoop S. Bhutani, M.D.

 

Reviews

Endoscopic Ultrasound in Idiopathic Acute Pancreatitis.

Tandon M, Topazian M.
Am J Gastroenterology 2001;96:705-9

 

EUS was performed in patients with idiopathic acute pancreatitis. EUS revealed a potential cause for pancreatitis in 68% of subjects including microlithiasis, chronic pancreatitis, pancreas divisum and pancreatic cancer. The authors concluded that EUS is a less invasive test than ERCP,demonstrated an etiology for idiopathic acute pancreatitis in two-thirds of patients and most patients did not require an ERCP in the follow-up period.

 

Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS.

Brandwein SL, Farrell JJ, Centeno BA, Brugge WR.
Gastrointestinal Endoscopy 2001;53:722-7

 

The study included 96 patients with solid, cystic and intraductal lesions of the pancreas. EUS-guided FNA provided evidence of malignancy in solid, cystic and ductal lesions with sensitivities of 59.5%, 50% and 60% respectively. EUS staging accuracy was better for cystic lesions(100%) and solid tumors(85%). Even though the sensitivity for EUS guided FNA was comparable between solid, cystic and intraductal lesions, the staging accuracy of EUS for intraductal lesions was significantly lower at 47%.

 

Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma.

Vazquez-Sequeiros E, Norton ID, Clain JE, et al.
Gastrointestinal Endoscopy 2001;53:751-7

 

The study included 74 patients with esophageal cancer in whom the results of EUS versus EUS-FNA for lymph node staging were compared. The authors concluded that EUS-FNA is more sensitive and accurate than EUS alone for preoperative staging of locoregional and celiac lymph nodes associated with esophageal carcinoma and this technique should be routinely performed when treatment decisions will be affected by the nodal stage.

These three articles continue to define the role of EUS as a diagnostic test.

Tandon et al have provided data which supports the role of EUS as a less invasive way (relative to ERCP) to suggest an etiology for pancreatitis. In some cases, their subjects will eventually require ERCP (microlithiasis), but in other instances, EUS can be the definative procedure. This is especially important for the diagnosis and staging of early pancreatic tumors.

To that end, Brandwein et all have examined the accuracy of EUS in evaluating potentially malignant pancreatic lesions. Their group points out some limitations in using EUS, but it still seems to be the most accurate method (relative to invasiveness) overall in the current available methods of assessing lesions of the pancreas.

Whereas Tandon, et al have shown the utility of EUS as a less invasive test, Vasques-Sequeiros et al have demonstrated the improved diagnostic yield of EUS when combined with needle aspiration in nodal staging of esophageal tumors. It is not surprising that aspiration is more accurate than imaging alone, since nodes can enlarge for non-malignant reasons (imaging false positives), and small nodes can contain cancer (imaging false negatives). As with any aspiration technique, however, a negative sample does not mean that malignancy is not present. Still, improved accuracy should provide better information from which one can ultimately base decisions on the need for neoadjuvant therapy.

 

 




Editorial Board:
Manoop S. Bhutani, M.D.
Galveston, TX
William R. Brugge, M.D.
Boston, MA
Peter R. McNally, D.O.
Denver, CO
Iqbal S. Sandhu, M.D.
Salt Lake City, UT
Thomas J. Savides, M.D.
San Diego, CA

Copyright © 2002, University of Colorado, All Rights Reserved
Privacy Policy